Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Developmental effects of SSRIs: lessons learned from animal studies.

Borue X, Chen J, Condron BG.

Int J Dev Neurosci. 2007 Oct;25(6):341-7. Review.

2.

Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy.

Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I.

Autism Res. 2013 Jun;6(3):149-68. doi: 10.1002/aur.1288. Review.

PMID:
23495208
3.

Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.

Gur TL, Kim DR, Epperson CN.

Psychopharmacology (Berl). 2013 Jun;227(4):567-82. doi: 10.1007/s00213-013-3115-8. Review.

4.

Perinatal selective serotonin reuptake inhibitor exposure: impact on brain development and neural plasticity.

Pawluski JL.

Neuroendocrinology. 2012;95(1):39-46. doi: 10.1159/000329293. Review.

PMID:
21893935
6.
7.

Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy.

Ornoy A, Koren G.

Semin Fetal Neonatal Med. 2014 Jun;19(3):188-94. doi: 10.1016/j.siny.2013.11.007. Review.

PMID:
24321501
8.

[SSRI during pregnancy and risk of fetal neurotoxicity. Follow precautions and look for other therapeutic alternatives].

Högberg U, Wang M.

Lakartidningen. 2005 Jan 17-23;102(3):113-5. Review. Swedish.

PMID:
15712734
9.

The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review.

Olivier JD, Blom T, Arentsen T, Homberg JR.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 1;35(6):1400-8. doi: 10.1016/j.pnpbp.2010.09.013. Review.

PMID:
20883714
10.

The genetics of selective serotonin reuptake inhibitors.

Kroeze Y, Zhou H, Homberg JR.

Pharmacol Ther. 2012 Dec;136(3):375-400. doi: 10.1016/j.pharmthera.2012.08.015. Review.

PMID:
22944042
11.

Fluoxetine during pregnancy: impact on fetal development.

Morrison JL, Riggs KW, Rurak DW.

Reprod Fertil Dev. 2005;17(6):641-50. Review.

PMID:
16263070
12.

Fetal serotonin signaling: setting pathways for early childhood development and behavior.

Oberlander TF.

J Adolesc Health. 2012 Aug;51(2 Suppl):S9-16. doi: 10.1016/j.jadohealth.2012.04.009. Review.

PMID:
22794534
13.

Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis.

Nemeroff CB, Owens MJ.

CNS Spectr. 2004 Jun;9(6 Suppl 4):23-31. Review.

PMID:
15181382
14.

Perinatal maternal stress and serotonin signaling: effects on pain sensitivity in offspring.

Knaepen L, Pawluski JL, Patijn J, van Kleef M, Tibboel D, Joosten EA.

Dev Psychobiol. 2014 Jul;56(5):885-96. doi: 10.1002/dev.21184. Review.

PMID:
24311362
15.
16.

Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implications.

Galbally M, Gentile S, Lewis AJ.

CNS Drugs. 2012 Oct 1;26(10):813-22. doi: 10.2165/11630310-000000000-00000. Review.

PMID:
22950489
17.

Selective serotonin reuptake inhibitors in pregnancy.

Bellissima V, Ververs TF, Visser GH, Gazzolo D.

Curr Med Chem. 2012;19(27):4554-61. Review.

PMID:
22876893
18.

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

Hyttel J.

Int Clin Psychopharmacol. 1994 Mar;9 Suppl 1:19-26. Review.

PMID:
8021435
19.

The safety of newer antidepressants in pregnancy and breastfeeding.

Gentile S.

Drug Saf. 2005;28(2):137-52. Review.

PMID:
15691224
20.

Serotonin and premature ejaculation: from physiology to patient management.

Giuliano F, Clément P.

Eur Urol. 2006 Sep;50(3):454-66. Review.

PMID:
16844284
Items per page

Supplemental Content

Support Center